Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000294993 is a natural antisense long noncoding RNA transcript annotated as 'novel transcript, antisense to PC'. It is transcribed from the opposite DNA strand relative to the protein-coding gene for pyruvate carboxylase, leading to potential overlap with the sense (PC) transcript. Such antisense transcripts can play diverse roles in regulating their cognate sense gene, including altering sense transcript abundance, modifying chromatin state, or affecting post-transcriptional processing. The functional significance, expression pattern, and direct gene regulatory actions of this specific transcript remain uncharacterized. Natural antisense transcripts are widespread throughout mammalian genomes and constitute a heterogeneous group with regulatory, but often poorly understood, gene expression effects. They are not typically considered therapeutic targets, nor do they have recognized functions as drug targets, disease biomarkers, or safety liabilities on their own, unless specifically validated in functional studies.
Transcriptional interference; RNA masking; Double-stranded RNA–dependent mechanisms (e.g., RNA interference); Chromatin remodeling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel antisense transcript to pyruvate carboxylase (ENSG00000294993).